{"transactions":[{"id":4636923,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-07T20:02:00.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":23463,"price":7.1977,"value":168879.6351,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $7.1977, and the range of prices were between $6.92 and $7.36. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":1519606,"source":{"system":"sec-edgar","filing":"0001193125-26-416953","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1909362/000119312526416953/ownership.xml","form_type":"4"}},{"id":4635908,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-06T20:01:36.000Z","date":"2026-10-05","kind":"sale","planned":false,"acquired":false,"shares":61696,"price":6.8372,"value":421827.8912,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Issuer has adopted a 'sell-to-cover' policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and release of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":1543069,"source":{"system":"sec-edgar","filing":"0001193125-26-415527","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1909362/000119312526415527/ownership.xml","form_type":"4"}},{"id":4618197,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-09-15T20:44:04.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":315000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Beginning on September 8, 2026, 1/48th of the shares subject to the option shall vest in equal monthly installments over a four-year period."}],"balance_after":315000,"derivative":{"exercise_price":8.91,"expiration_date":"2036-09-14","underlying":"Common Stock","underlying_shares":315000},"source":{"system":"sec-edgar","filing":"0001193125-26-392025","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1909362/000119312526392025/ownership.xml","form_type":"4"}},{"id":4618196,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-15T20:44:04.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan."}],"balance_after":1604765,"source":{"system":"sec-edgar","filing":"0001193125-26-392025","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1909362/000119312526392025/ownership.xml","form_type":"4"}},{"id":4617557,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-09-15T00:07:15.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":155000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Beginning on September 8, 2026, 1/48th of the shares subject to the option shall vest in equal monthly installments over a four-year period."}],"balance_after":155000,"derivative":{"exercise_price":10.42,"expiration_date":"2036-09-09","underlying":"Common Stock","underlying_shares":155000},"source":{"system":"sec-edgar","filing":"0001193125-26-391012","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1909362/000119312526391012/ownership.xml","form_type":"4"}},{"id":4617556,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-15T00:07:15.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan."}],"balance_after":1494765,"source":{"system":"sec-edgar","filing":"0001193125-26-391012","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1909362/000119312526391012/ownership.xml","form_type":"4"}},{"id":4613240,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-09T20:02:44.000Z","date":"2026-09-08","kind":"sale","planned":true,"acquired":false,"shares":23429,"price":10.9158,"value":255746.2782,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $10.9158, and the range of prices were between $10.72 and $11.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":1449765,"source":{"system":"sec-edgar","filing":"0001193125-26-386431","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1909362/000119312526386431/ownership.xml","form_type":"4"}},{"id":4311,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-04T20:02:40.000Z","date":"2026-09-03","kind":"sale","planned":false,"acquired":false,"shares":61888,"price":11.1555,"value":690391.584,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Issuer has adopted a 'sell-to-cover' policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and release of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $11.1555, and the range of prices were between $11.0270 and $11.1556. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":1473194,"source":{"system":"sec-edgar","filing":"0001193125-26-383618","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1909362/000119312526383618/ownership.xml","form_type":"4"}},{"id":772227,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-20T01:50:02.000Z","date":"2026-05-19","kind":"sale","planned":false,"acquired":false,"shares":27116,"price":9.0077,"value":244252.7932,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Issuer has adopted a 'sell-to-cover' policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and release of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $9.0077, and the range of prices were between $8.7383 and $9.0104. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":1535082,"source":{"system":"sec-edgar","filing":"0001193125-26-231506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312526231506/ownership.xml","form_type":"4"}},{"id":897098,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-18T23:48:01.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":14600,"price":4,"value":58400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards."}],"balance_after":1562198,"source":{"system":"sec-edgar","filing":"0001193125-26-057667","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312526057667/ownership.xml","form_type":"4"}},{"id":897097,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-18T23:48:01.000Z","date":"2026-02-15","kind":"grant","planned":false,"acquired":true,"shares":366850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan."}],"balance_after":1576798,"source":{"system":"sec-edgar","filing":"0001193125-26-057667","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312526057667/ownership.xml","form_type":"4"}},{"id":969598,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-16T02:19:28.000Z","date":"2025-12-15","kind":"sale","planned":true,"acquired":false,"shares":3187,"price":6,"value":19122.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on July 23, 2024."}],"balance_after":1209948,"source":{"system":"sec-edgar","filing":"0001193125-25-319696","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525319696/ownership.xml","form_type":"4"}},{"id":971334,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-13T00:19:00.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":319331,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 12, 2025, the Issuer cancelled, pursuant to an option exchange, the options listed in Table II. In exchange for the cancelled options, the Reporting Person received the RSUs reported in Table I."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares will vest on July 19, 2025, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":12,"expiration_date":"2034-07-17","underlying":"Common Stock","underlying_shares":319331},"source":{"system":"sec-edgar","filing":"0001193125-25-317980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525317980/ownership.xml","form_type":"4"}},{"id":971333,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-13T00:19:00.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":113999,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 12, 2025, the Issuer cancelled, pursuant to an option exchange, the options listed in Table II. In exchange for the cancelled options, the Reporting Person received the RSUs reported in Table I."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares will vest on July 19, 2025, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":13.47,"expiration_date":"2034-05-01","underlying":"Common Stock","underlying_shares":113999},"source":{"system":"sec-edgar","filing":"0001193125-25-317980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525317980/ownership.xml","form_type":"4"}},{"id":971332,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-13T00:19:00.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":26450,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 12, 2025, the Issuer cancelled, pursuant to an option exchange, the options listed in Table II. In exchange for the cancelled options, the Reporting Person received the RSUs reported in Table I."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Vesting is monthly over a 48-month period starting January 1, 2024 in equal monthly amounts."}],"balance_after":0,"derivative":{"exercise_price":5.18,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":26450},"source":{"system":"sec-edgar","filing":"0001193125-25-317980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525317980/ownership.xml","form_type":"4"}},{"id":971331,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-13T00:19:00.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":257319,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 12, 2025, the Issuer cancelled, pursuant to an option exchange, the options listed in Table II. In exchange for the cancelled options, the Reporting Person received the RSUs reported in Table I."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares vest on January 1, 2022, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":5.01,"expiration_date":"2030-12-17","underlying":"Common Stock","underlying_shares":257319},"source":{"system":"sec-edgar","filing":"0001193125-25-317980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525317980/ownership.xml","form_type":"4"}},{"id":971330,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-13T00:19:00.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":51463,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 12, 2025, the Issuer cancelled, pursuant to an option exchange, the options listed in Table II. In exchange for the cancelled options, the Reporting Person received the RSUs reported in Table I."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares vested on February 22, 2022, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":5.01,"expiration_date":"2030-12-17","underlying":"Common Stock","underlying_shares":51463},"source":{"system":"sec-edgar","filing":"0001193125-25-317980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525317980/ownership.xml","form_type":"4"}},{"id":971329,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-13T00:19:00.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":100577,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 12, 2025, the Issuer cancelled, pursuant to an option exchange, the options listed in Table II. In exchange for the cancelled options, the Reporting Person received the RSUs reported in Table I."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares vested on February 22, 2022, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":5.01,"expiration_date":"2031-02-23","underlying":"Common Stock","underlying_shares":100577},"source":{"system":"sec-edgar","filing":"0001193125-25-317980","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525317980/ownership.xml","form_type":"4"}},{"id":971328,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-13T00:19:00.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":869136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units award granted under the Issuer's 2024 Equity Incentive Plan (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 12, 2025, the Issuer cancelled, pursuant to an option exchange, the options listed in Table II. In exchange for the cancelled options, the Reporting Person received the RSUs reported in Table I."}],"balance_after":1213135,"source":{"system":"sec-edgar","filing":"0001193125-25-317980","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525317980/ownership.xml","form_type":"4"}},{"id":997877,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-11-18T01:37:55.000Z","date":"2025-11-17","kind":"sale","planned":true,"acquired":false,"shares":6375,"price":3.376,"value":21522.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on July 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $3.376, and the range of prices were between $3.19 and $3.53. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":343999,"source":{"system":"sec-edgar","filing":"0001193125-25-285004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525285004/ownership.xml","form_type":"4"}},{"id":997876,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-11-18T01:37:55.000Z","date":"2025-11-15","kind":"tax_withholding","planned":true,"acquired":false,"shares":6347,"price":3.25,"value":20627.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards."}],"balance_after":350374,"source":{"system":"sec-edgar","filing":"0001193125-25-285004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525285004/ownership.xml","form_type":"4"}},{"id":1016882,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-10-18T00:44:06.000Z","date":"2025-10-17","kind":"sale","planned":true,"acquired":false,"shares":25500,"price":6,"value":153000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on July 23, 2024."}],"balance_after":356721,"source":{"system":"sec-edgar","filing":"0001909362-25-000004","document":"form4-10182025_121003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000190936225000004/form4-10182025_121003.xml","form_type":"4"}},{"id":1064083,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-08-19T00:15:13.000Z","date":"2025-08-15","kind":"tax_withholding","planned":true,"acquired":false,"shares":4472,"price":2.75,"value":12298.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards."}],"balance_after":382221,"source":{"system":"sec-edgar","filing":"0001415889-25-022224","document":"form4-08182025_080810.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000141588925022224/form4-08182025_080810.xml","form_type":"4"}},{"id":1064082,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-08-19T00:15:13.000Z","date":"2025-08-15","kind":"sale","planned":true,"acquired":false,"shares":25500,"price":2.7286,"value":69579.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 23, 2024, to satisfy income tax obligations associated with the vesting of restricted stock unit awards."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $2.7286, and the range of prices were between $2.60 and $2.80. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":386693,"source":{"system":"sec-edgar","filing":"0001415889-25-022224","document":"form4-08182025_080810.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000141588925022224/form4-08182025_080810.xml","form_type":"4"}},{"id":1064081,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-08-19T00:15:13.000Z","date":"2025-05-15","kind":"tax_withholding","planned":true,"acquired":false,"shares":4472,"price":2.13,"value":9525.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards."}],"balance_after":412193,"source":{"system":"sec-edgar","filing":"0001415889-25-022224","document":"form4-08182025_080810.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000141588925022224/form4-08182025_080810.xml","form_type":"4"}},{"id":1217565,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-07T21:35:00.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects reduction in the number of shares subject to the RSU granted on July 22, 2024 from 228,905 shares to 216,665 shares. The equity award was originally calculated based on the maximum offering size of the Company's initial public offering (IPO) and such award was subsequently adjusted following the partial exercise of the underwriters option to purchase additional shares in connection with the IPO."}],"balance_after":416665,"source":{"system":"sec-edgar","filing":"0001415889-25-007431","document":"form4-03072025_090355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000141588925007431/form4-03072025_090355.xml","form_type":"4"}},{"id":1450502,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-07-23T00:18:50.000Z","date":"2024-07-18","kind":"grant","planned":false,"acquired":true,"shares":343811,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares will vest on July 19, 2025, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":343811,"derivative":{"exercise_price":12,"expiration_date":"2034-07-17","underlying":"Common Stock","underlying_shares":343811},"source":{"system":"sec-edgar","filing":"0001415889-24-019905","document":"form4-07232024_120741.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000141588924019905/form4-07232024_120741.xml","form_type":"4"}},{"id":1450501,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":9999,"kind":"person","name":"Aslan Fred","position":1,"cik":"0001909362","reported_name":"Aslan Fred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-23T00:18:50.000Z","date":"2024-07-22","kind":"grant","planned":false,"acquired":true,"shares":228905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan."}],"balance_after":228905,"source":{"system":"sec-edgar","filing":"0001415889-24-019905","document":"form4-07232024_120741.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000141588924019905/form4-07232024_120741.xml","form_type":"4"}}]}